22(S)-Hydroxycholesterol, an antagonist of LXR, inhibits breast cancer cell migration

被引:0
|
作者
Hwang, Sewon
Na, Tae Young
Na, Hyelin
Lee, Minho
Lee, Mi-Ock
机构
关键词
D O I
10.1158/1538-7445.AM2016-1637
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1637
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Frondoside A inhibits human breast cancer cell survival, migration, invasion and the growth of breast tumor xenografts
    Al Marzouqi, Nadia
    Iratni, Rabah
    Nemmar, Abderrahim
    Arafat, Kholoud
    Al Sultan, Mahmood Ahmed
    Yasin, Javed
    Collin, Peter
    Mester, Jan
    Adrian, Thomas E.
    Attoub, Samir
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 668 (1-2) : 25 - 34
  • [22] Selective ETAR antagonist atrasentan inhibits hypoxia-induced breast cancer cell invasion
    Smollich, M.
    Goette, M.
    Kersting, C.
    Fischgraebe, J.
    Kiesel, L.
    Wuelfing, P.
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 108 (02) : 175 - 182
  • [23] Selective ETAR antagonist atrasentan inhibits hypoxia-induced breast cancer cell invasion
    M. Smollich
    M. Götte
    C. Kersting
    J. Fischgräbe
    L. Kiesel
    P. Wülfing
    Breast Cancer Research and Treatment, 2008, 108 : 175 - 182
  • [24] A selective T-type calcium channel antagonist inhibits breast cancer cell growth
    Taylor, JT
    Rider, B
    Huang, LP
    Keyser, BM
    Agrawal, K
    Li, M
    FASEB JOURNAL, 2004, 18 (05): : A996 - A997
  • [25] Ambrisentan, an endothelin receptor type A-selective antagonist, inhibits cancer cell migration, invasion, and metastasis
    Lucy Kappes
    Ruba L. Amer
    Sabine Sommerlatte
    Ghada Bashir
    Corinna Plattfaut
    Frank Gieseler
    Timo Gemoll
    Hauke Busch
    Abeer Altahrawi
    Ashraf Al-Sbiei
    Shoja M. Haneefa
    Kholoud Arafat
    Lena F. Schimke
    Nadia El Khawanky
    Kai Schulze-Forster
    Harald Heidecke
    Anja Kerstein-Staehle
    Gabriele Marschner
    Silke Pitann
    Hans D. Ochs
    Antje Mueller
    Samir Attoub
    Maria J. Fernandez-Cabezudo
    Gabriela Riemekasten
    Basel K. al-Ramadi
    Otavio Cabral-Marques
    Scientific Reports, 10
  • [26] Ambrisentan, an endothelin receptor type A-selective antagonist, inhibits cancer cell migration, invasion, and metastasis
    Kappes, Lucy
    Amer, Ruba L.
    Sommerlatte, Sabine
    Bashir, Ghada
    Plattfaut, Corinna
    Gieseler, Frank
    Gemoll, Timo
    Busch, Hauke
    Altahrawi, Abeer
    Al-Sbiei, Ashraf
    Haneefa, Shoja M.
    Arafat, Kholoud
    Schimke, Lena F.
    El Khawanky, Nadia
    Schulze-Forster, Kai
    Heidecke, Harald
    Kerstein-Staehle, Anja
    Marschner, Gabriele
    Pitann, Silke
    Ochs, Hans D.
    Mueller, Antje
    Attoub, Samir
    Fernandez-Cabezudo, Maria J.
    Riemekasten, Gabriela
    al-Ramadi, Basel K.
    Cabral-Marques, Otavio
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [27] Berberine and chemotherapeutic drugs synergistically inhibits cell proliferation and migration of breast cancer cells
    Chen, Yao
    Zhang, Haiyun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (12): : 13243 - 13250
  • [28] MicroRNA-146a inhibits cell migration and invasion by targeting RhoA in breast cancer
    Liu, Qin
    Wang, Wei
    Yang, Xiongfa
    Zhao, Dongxiao
    Li, Fangqiong
    Wang, Hai
    ONCOLOGY REPORTS, 2016, 36 (01) : 189 - 196
  • [29] Lotus leaf extract inhibits ER- breast cancer cell migration and metastasis
    Tong, Yuelin
    Li, Zhongwei
    Wu, Yikuan
    Zhu, Shenglong
    Lu, Keke
    He, Zhao
    NUTRITION & METABOLISM, 2021, 18 (01)
  • [30] Knockdown of CARD14 Inhibits Cell Proliferation and Migration in Breast Cancer Cells
    Lim, Ji-Yeon
    Kim, Seok Won
    Kim, Byeol
    Park, Seon-Joo
    ANTICANCER RESEARCH, 2020, 40 (04) : 1953 - 1962